Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials

Therapeutic Innovation & Regulatory Science
Daphne GuinnIra Shoulson

Abstract

Confirmatory phase III trials aim to provide decisive evidence about a medical product's safety and efficacy. Although these trials are planned and conducted based on accumulated knowledge, they are not without risk or uncertainty. A trial prematurely concluding contributes to great loss in both financial and human research resources. We categorized and evaluated trials concluded prematurely after recruitment had begun, as registered in Clinical Trials.gov between January 2013 and August 2017. We found 9828 registered interventional phase III trials; of those, 320 were concluded prematurely. Many clinical trials were concluded prematurely for reasons related to reducing participant risk, such as interim stopping for safety, efficacy, or futility. Yet, 70% trials were halted for other reasons, such as insufficient recruitment (the most often cited reason) or unspecified business decisions. Of all prematurely concluded trials, 102 trials evaluated 72 different novel therapeutics; in 66.7% of these trials, the clinical development program was stopped entirely. Most of the prematurely concluded trials (78%) had not provided results to ClinicalTrials.gov at the time of this analysis. Evaluation of the factors that influence prematur...Continue Reading

References

Aug 11, 2005·JAMA : the Journal of the American Medical Association·David I Shalowitz, Franklin G Miller
Dec 10, 2008·Archives of Neurology·E Ray DorseyUNKNOWN Huntington Study Group TREND-HD Investigators
Jul 3, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Anneke T SchroenCraig L Slingluff
Jan 1, 2011·Advances in Medical Education and Practice·Sayeeda RahmanUrban Ja D'Souza
Dec 6, 2014·Clinical Trials : Journal of the Society for Clinical Trials·Benjamin CarlisleNathalie MacKinnon
Feb 26, 2016·Clinical Trials : Journal of the Society for Clinical Trials·Aylin SertkayaTrinidad Beleche
Jul 15, 2016·Translational Lung Cancer Research·Cecilia Zappa, Shaker A Mousa
Sep 17, 2016·The New England Journal of Medicine·Deborah A ZarinSarah Carr
Jan 22, 2017·Journal of Medical Ethics·Luke GelinasI Glenn Cohen
Mar 18, 2017·The New England Journal of Medicine·Paul M RidkerUNKNOWN SPIRE Cardiovascular Outcome Investigators
Jun 24, 2017·JACC. Cardiovascular Interventions·John A BittlSteven M Bradley
Aug 18, 2017·Neurology·Christopher A BeckUNKNOWN Connect.Parkinson Investigators
Sep 25, 2017·Nature Reviews. Drug Discovery·Stephen P ArnerićJeffrey A Kaye
Jun 23, 2018·JAMA : the Journal of the American Medical Association·Charlene A WongRobert M Califf

❮ Previous
Next ❯

Citations

Oct 18, 2019·Journal of Medical Internet Research·François Carbonnel, Gregory Ninot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Carlo Di Padova
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Tilman B DruekeFrancesco Locatelli
JAMA : the Journal of the American Medical Association
An-Wen ChanDavid Moher
JAMA : the Journal of the American Medical Association
Julien Mancini, Claire Julian Reynier
© 2022 Meta ULC. All rights reserved